P27, SKP2, and extra-cellular signal-related kinase signalling in human salivary gland mucoepidermoid carcinoma

Oral Oncology

Volumn 42, Issue 10, 2006, Pages 1005-1010

  Handra Luca, Adriana ^a   Ruhin, Blandine ^b   Lesty, Claude ^b   Fouret, Pierre ^c  

^a UNIVERSITÉ PARIS 13   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Carcinoma; Mucoepidermoid; Pathology; Proliferation; Salivary gland

Indexed keywords

CYCLIN A; CYCLIN D1; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2;

ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SALIVARY GLAND; SALIVARY GLAND CARCINOMA; SIGNAL TRANSDUCTION;

CARCINOMA, MUCOEPIDERMOID; CELL PROLIFERATION; CYCLIN D; CYCLINS; DISEASE-FREE SURVIVAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; S-PHASE KINASE-ASSOCIATED PROTEINS; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33750206869     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.12.022     Document Type: Article

References (22)

1. Sessions R., Harrison L., and Forastiere A. Tumors of the salivary gland and paragangliomas. In: DeVita V.T., Helman S., and Rosenberg S.A. (Eds). Cancer: principles and practice of oncology (2000), Lippincott Williams and Wilkins, Philadelphia, PA 886-900
2. Ellis G.L., and Auclair P. Tumors of the salivary glands (1996), Armed Forces Institute of Pathology, Washington, DC p. 155-75
3. Handra-Luca A., Bilal H., Bertrand J.C., and Fouret P. Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation. Am J Pathol 163 3 (2003) 957-967
4. Seger R., and Krebs E.G. The MAPK signaling cascade. FASEB J 9 9 (1995) 726-735
5. Filmus J., Robles A.I., Shi W., Wong M.J., Colombo L.L., and Conti C.J. Induction of cyclin D1 overexpression by activated ras. Oncogene 9 12 (1994) 3627-3633
6. Cheng M., Sexl V., Sherr C.J., and Roussel M.F. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase (MEK1). Proc Natl Acad Sci USA 95 3 (1998) 1091-1096
7. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13 12 (1999) 1501-1512
8. Jackson R.J., Adnane J., Coppola D., Cantor A., Sebti S.M., and Pledger W.J. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models. Oncogene 21 55 (2002) 8486-8497
9. Lloyd R.V., Erickson L.A., Jin L., et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 154 2 (1999) 313-323
10. Blain S.W., Scher H.I., Cordon-Cardo C., and Koff A. p27 as a target for cancer therapeutics. Cancer Cell 3 2 (2003) 111-115
11. Bashir T., and Pagano M. Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis. Adv Cancer Res 88 (2003) 101-144
12. Clurman B.E., and Porter P. New insights into the tumor suppression function of P27(kip1). Proc Natl Acad Sci USA 95 26 (1998) 15158-15160
13. Bootz F., Hermanek P., Howaldt H., Hutter R., Paterok E., and Sobin G. TNM atlas. 4th ed. (1998), Springer, Paris
14. Porter P.L., Malone K.E., Heagerty P.J., et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3 2 (1997) 222-225
15. Matsuda Y., Ichida T., Genda T., Yamagiwa S., Aoyagi Y., and Asakura H. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma. Clin Cancer Res 9 9 (2003) 3389-3396
16. Oliveira A.M., Okuno S.H., Nascimento A.G., and Lloyd R.V. Skp2 protein expression in soft tissue sarcomas. J Clin Oncol 21 4 (2003) 722-727
17. Sanchez-Beato M., Camacho F.I., Martinez-Montero J.C., et al. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells. Blood 94 2 (1999) 765-772
18. Skalova A., Lehtonen H., von Boguslawski, and Leivo I. Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections. Hum Pathol 25 9 (1994) 929-935
19. LaBaer J., Garrett M.D., Stevenson L.F., et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev 11 7 (1997) 847-862
20. Blain S.W., Montalvo E., and Massague J. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J Biol Chem 272 41 (1997) 25863-25872
21. Cheng M., Olivier P., Diehl J.A., et al. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. Embo J 18 6 (1999) 1571-1583
22. Shoji M., Dobashi Y., Morinaga S., Jiang S.X., and Kameya T. Tumor extension and cell proliferation in adenocarcinomas of the lung. Am J Pathol 154 3 (1999) 909-918